Zuclopenthixol, a combined dopamine D1/D2 antagonist, versus haloperidol, a dopamine D2 antagonist, in tardive dyskinesia

European Neuropsychopharmacology

Volumn 1, Issue 4, 1991, Pages 541-548

  Lublin, Henrik ^a   Gerlach, Jes ^a   Hagert, Ulf ^b   Meidahl, Birgit ^a   Mølbjerg, Cecilia ^c   Pederson, Vagn ^c   Rendtorff, Claus ^a   Tolvanen, Erkki ^b  

^a Sct Hans Hospital   (Denmark)

^b Nickby Sjukhus Nickby Finland ^*  (Finland)

^c H LUNDBECK A S   (Denmark)

Author keywords

Dopamine D1 and D2 receptors; Dopamine supersensitivity; Parkinsonism; Tardive dyskinesia

Indexed keywords

CLOPENTHIXOL; HALOPERIDOL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; DYSKINESIA; FEMALE; HUMAN; IATROGENIC DISEASE; MALE; PARKINSON DISEASE; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE;

ADULT; AGED; CLOPENTHIXOL; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; DYSKINESIA, DRUG-INDUCED; FEMALE; HALOPERIDOL; HUMAN; MALE; MIDDLE AGE; PARKINSON DISEASE, SECONDARY; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS;

EID: 0026306042     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-977X(91)90008-I     Document Type: Article

References (30)

1. Specific high-performance liquid chromatographic method for estimation of cis(Z)-and trans(E)isomers of clopenthixol and N-dealkyl metabolite
2. Dyskinesia — Research and treatment
3. Behavioural correlates to dopamine D-1 and D-2 antagonists
4. Pharmacological differentiation of dopamine D-1 and D-2 antagonists after single and repeated administration
5. D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics
6. Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine and clozapine
7. Classification of abnormal involuntary movements in psychiatric patients
8. Tardive dyskinesia
9. Remoxipride, a new selective D2 antagonist, and haloperidol in Cebus monkeys
10. Pharmacological sensitization to intermittent neuroleptic treatment
11. A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesia
12. Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis
13. ECDEU Assessment Manual for Psychopharmacology
14. Cis(Z)-clopenthixol and haloperidol in chronic schizophrenic patients — a double-blind clinical multicentre investigation
15. Zuclopenthixol and haloperidol in patients with acute psychotic states. A double-blind multi-centre study
16. Changes in dopamine synthesis in the supersensitivity phase after treatment with a single dose of neuroleptics
17. Tardive dyskinesia and subtyping of schizophrenia
18. The pharmacology of tardive dyskinesias
19. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic- treated patients
20. Behavioural effects of dopamine D-1 and D-2 receptor agonists in monkeys previously treated with haloperidol
21. Aspects of dopamine D-1 and D-2 receptor manipulation in cebus apella monkeys
22. Effects of chlorprothixen haloperidol and perphenazin in tardive dyskinesia and parkinsonism
23. Brief psychiatric rating scale
24. Effect of tiapride in tardive dyskinesia
25. New aspects on the role of dopamine, acetylcholine, and GABA in the development of tardive dyskinesia
26. Induction of oral dyskinesia in naive rats by D1 stimulation
27. History and definition of tardive dyskinesia